Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
24.19
0.26 (1.09%)
At close: May 02, 2025, 3:59 PM
24.18
-0.04%
After-hours: May 02, 2025, 05:57 PM EDT
1.09%
Bid 24.18
Market Cap 137.19B
Revenue (ttm) 63.63B
Net Income (ttm) 8.01B
EPS (ttm) 1.38
PE Ratio (ttm) 17.53
Forward PE 8.03
Analyst Hold
Ask 24.19
Volume 28,681,997
Avg. Volume (20D) 52,634,438
Open 24.27
Previous Close 23.93
Day's Range 23.97 - 24.30
52-Week Range 20.92 - 31.54
Beta 0.60

About PFE

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable an...

Sector Healthcare
IPO Date Jun 1, 1972
Employees 81,000
Stock Exchange NYSE
Ticker Symbol PFE
Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for PFE stock is "Hold." The 12-month stock price forecast is $29.5, which is an increase of 21.95% from the latest price.

Stock Forecasts

Earnings Surprise

Pfizer has released their quartely earnings on Apr 29, 2025:
  • Revenue of $13.71B misses estimates by $235M, with -7.82% YoY decline.
  • EPS of 0.92 exceeds estimates by 0.25, with 12.20% YoY growth.
  • 3 days ago
    +3.21%
    Pfizer shares are trading higher following a Q1 EP... Unlock content with Pro Subscription
    1 month ago
    -1.33%
    Pfizer shares are trading lower following a Wall Street Journal report suggesting US prosecutors are probing a tip about the timing of the company's COVID-19 vaccine, which allegedly came via GSK.